Background:Hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(ICC)are the most common subtypes of primary liver cancer,but nationwide incidence of both liver cancer subtypes have never been reported in C...Background:Hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(ICC)are the most common subtypes of primary liver cancer,but nationwide incidence of both liver cancer subtypes have never been reported in China.We aimed to estimate the most recent incidence of HCC and ICC and temporal trends in China based on the most updated data from high qualified population-based cancer registries(covering 13.1%of the national population),in comparison to those in the United States at the same period.Methods:We used data from 188 Chinese population-based cancer registries covering 180.6 million population of China to estimate the nationwide incidence of HCC and ICC in 2015.And 22 population-based cancer registries’data were used to estimate the trends of HCC and ICC incidence from 2006 to 2015.Multiple imputation by chained equations method was used to impute liver cancer cases with unknown subtype(50.8%).We used data from 18 population-based registries from the Surveillance,Epidemiology,and End Results program to analyze incidence of HCC and ICC in the United States.Results:In China,an estimated 301,500 and 61,900 newly diagnosed HCC and ICC occurred in 2015.The overall age-standardized rates(ASRs)of HCC incidence decreased by 3.9%per year.For ICC incidence,the overall ASR was relatively stable,but increased in the population of over 65 years old.Subgroup analysis by age showed that the ASR of HCC incidence had the sharpest decline in population who were less than 14 years old and received neonatally hepatitis B virus(HBV)vaccination.In the United States,though the incidence of HCC and ICC were lower than those in China,the overall HCC and ICC incidence increased by 3.3%and 9.2%per year.Conclusions:China still faces with a heavy burden of liver cancer incidence.Our results may further support the beneficial effect of Hepatitis B vaccination on reduction of HCC incidence.Both healthy lifestyle promotion and infection control are needed for future liver cancer control and prevention for China and the United States.展开更多
Background:Neuroendocrine neoplasms(NENs)are rare tumors characterized by variable biology and delayed diagnosis.However,the nationwide epidemiology of NENs has never been reported in China.We aimed to estimate the in...Background:Neuroendocrine neoplasms(NENs)are rare tumors characterized by variable biology and delayed diagnosis.However,the nationwide epidemiology of NENs has never been reported in China.We aimed to estimate the incidence and survival statistics of NENs in China,in comparison to those in the United States during the same period.Methods:Based on the data from 246 population-based cancer registries covering 272.5 million people of China,we calculated age-specific incidence on NENs in 2017 and multiplied by corresponding national population to estimate the nationwide incidence in China.The data of 22 population-based cancer registries were used to estimate the trends of NENs incidence from 2000 to 2017 through the Joinpoint regression model.We used the cohort approach to analyze the 5-year age-standardized relative survival by sex,age group,and urban-rural area between 2008 and 2013,based on data from 176 high-quality cancer registries.We used data from the Surveillance,Epidemiology,and End Results(SEER)18 program to estimate the comparable incidence and survival of NENs in the United States.Results:The overall age-standardized rate(ASR)of NENs incidence was lower in China(1.14 per 100,000)than in the United States(6.26 per 100,000).The most common primary sites were lungs,pancreas,stomach,and rectum in China.The ASRs of NENs incidence increased by 9.8%and 3.6%per year in China and the United States,respectively.The overall 5-year relative survival in China(36.2%)was lower than in the United States(63.9%).The 5-year relative survival was higher for female patients than male patients,and was higher in urban areas than in rural areas.Conclusions:The disparities in burden of NENs persist across sex,area,age group,and site in China and the United States.These findings may provide a scientific basis on prevention and control of NENs in the two countries.展开更多
基金The funding resources of this study were National Key R&D Program of China(2016YFC1302502,2017YFC0908103)Major State Basic Innovation Program of the Chinese Academy of Medical Sciences(2019-I2M-2-004).
文摘Background:Hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(ICC)are the most common subtypes of primary liver cancer,but nationwide incidence of both liver cancer subtypes have never been reported in China.We aimed to estimate the most recent incidence of HCC and ICC and temporal trends in China based on the most updated data from high qualified population-based cancer registries(covering 13.1%of the national population),in comparison to those in the United States at the same period.Methods:We used data from 188 Chinese population-based cancer registries covering 180.6 million population of China to estimate the nationwide incidence of HCC and ICC in 2015.And 22 population-based cancer registries’data were used to estimate the trends of HCC and ICC incidence from 2006 to 2015.Multiple imputation by chained equations method was used to impute liver cancer cases with unknown subtype(50.8%).We used data from 18 population-based registries from the Surveillance,Epidemiology,and End Results program to analyze incidence of HCC and ICC in the United States.Results:In China,an estimated 301,500 and 61,900 newly diagnosed HCC and ICC occurred in 2015.The overall age-standardized rates(ASRs)of HCC incidence decreased by 3.9%per year.For ICC incidence,the overall ASR was relatively stable,but increased in the population of over 65 years old.Subgroup analysis by age showed that the ASR of HCC incidence had the sharpest decline in population who were less than 14 years old and received neonatally hepatitis B virus(HBV)vaccination.In the United States,though the incidence of HCC and ICC were lower than those in China,the overall HCC and ICC incidence increased by 3.3%and 9.2%per year.Conclusions:China still faces with a heavy burden of liver cancer incidence.Our results may further support the beneficial effect of Hepatitis B vaccination on reduction of HCC incidence.Both healthy lifestyle promotion and infection control are needed for future liver cancer control and prevention for China and the United States.
文摘Background:Neuroendocrine neoplasms(NENs)are rare tumors characterized by variable biology and delayed diagnosis.However,the nationwide epidemiology of NENs has never been reported in China.We aimed to estimate the incidence and survival statistics of NENs in China,in comparison to those in the United States during the same period.Methods:Based on the data from 246 population-based cancer registries covering 272.5 million people of China,we calculated age-specific incidence on NENs in 2017 and multiplied by corresponding national population to estimate the nationwide incidence in China.The data of 22 population-based cancer registries were used to estimate the trends of NENs incidence from 2000 to 2017 through the Joinpoint regression model.We used the cohort approach to analyze the 5-year age-standardized relative survival by sex,age group,and urban-rural area between 2008 and 2013,based on data from 176 high-quality cancer registries.We used data from the Surveillance,Epidemiology,and End Results(SEER)18 program to estimate the comparable incidence and survival of NENs in the United States.Results:The overall age-standardized rate(ASR)of NENs incidence was lower in China(1.14 per 100,000)than in the United States(6.26 per 100,000).The most common primary sites were lungs,pancreas,stomach,and rectum in China.The ASRs of NENs incidence increased by 9.8%and 3.6%per year in China and the United States,respectively.The overall 5-year relative survival in China(36.2%)was lower than in the United States(63.9%).The 5-year relative survival was higher for female patients than male patients,and was higher in urban areas than in rural areas.Conclusions:The disparities in burden of NENs persist across sex,area,age group,and site in China and the United States.These findings may provide a scientific basis on prevention and control of NENs in the two countries.
